ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
Dow Jones
38,711.29
0.36%
US Dollar vs MXN
17.876
0.98%
Brent Oil
77.435
-0.90%
Bitcoin
70,348.06
2.24%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
04/06/202415:34Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
04/06/202415:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:REPXRiley Exploration Permian Inc
04/06/202415:33Edgar (US Regulatory)Form 8-K - Current reportNYSE:GTESGates Industrial Corporation PLC
04/06/202415:33PR Newswire (US)DR. PHIL'S EXCLUSIVE INTERVIEW WITH DONALD TRUMP TO AIR ON MERIT STREET MEDIA™ THURSDAY, JUNE 6
04/06/202415:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FUSNFusion Pharmaceuticals Inc
04/06/202415:32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TSLATesla Inc
04/06/202415:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAWHumacyte Inc
04/06/202415:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:LRHCLa Rosa Holdings Corporation
04/06/202415:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]AMEX:XXXXMax S&P 500 4x Leveraged ETN due October 30 2043
04/06/202415:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DHCNLDiversified Healthcare Trust
04/06/202415:30GlobeNewswire Inc.CORRECTION - OTC Markets Group Welcomes Verde Agritech Ltd. to OTCQXNPK.TO
04/06/202415:30GlobeNewswire Inc.Lifeward to Present at Sidoti Virtual Investor Conference on June 12NASDAQ:LFWDReWalk Robotics Ltd
04/06/202415:30Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]USOTC:NVSEFNovartis Ag Basel Namen Akt (PK)
04/06/202415:30Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNASDAQ:WBDWarner Brothers Discovery Inc
04/06/202415:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BETRWBetter Home and Finance Holding Company
04/06/202415:30GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024EU:DBVDBV Technologies
04/06/202415:30Business WireInfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024AMEX:INFUInfuSystems Holdings Inc
04/06/202415:30GlobeNewswire Inc.LanzaTech to Participate in Upcoming Investor EventsNASDAQ:LNZALanzaTech Global Inc
04/06/202415:30GlobeNewswire Inc.Cellectis obtient la désignation de médicament orphelin pour son produit CAR T allogénique UCART22 pour les patients atteints de leucémie lymphoblastique aiguëEU:ALCLSCellectis Nom Eo 05
04/06/202415:30Business WireJohnson & Johnson to Host Investor Conference Call on Second-Quarter ResultsNYSE:JNJJohnson and Johnson
04/06/202415:30GlobeNewswire Inc.Host Hotels & Resorts Announces Second Quarter 2024 Earnings Call to be Held on August 1, 2024NASDAQ:HSTHost Hotels and Resorts Inc
04/06/202415:30GlobeNewswire Inc.Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic LeukemiaTG:ZVACellectis Nom Eo 05
04/06/202415:30GlobeNewswire Inc.Greif Announces Price Increase for Uncoated Recycled Paperboard (URB)NYSE:GEF.BGreif Inc
04/06/202415:30GlobeNewswire Inc.Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mai 2024TG:DBVDBV Technologies
04/06/202415:30GlobeNewswire Inc.Actelis Receives New Orders to Supply Three Military Bases with Cyber-Hardened Networking Technology, Continues Momentum with U.S. MilitaryNASDAQ:ASNSActelis Networks Inc
04/06/202415:30Business WireAEO Inc. Announces Participation in the TD Cowen Future of the Consumer ConferenceNYSE:AEOAmerican Eagle Outfitters Inc
04/06/202415:30GlobeNewswire Inc.Weatherford Signs Memorandum of Understanding with QatarEnergy to Advance Tawteen In-Country Value ProgramNASDAQ:WFRDWeatherford International PLC
04/06/202415:30Business WirePhillips 66 to Speak at the J.P. Morgan 2024 Energy, Power & Renewables ConferenceNYSE:PSXPhillips 66
04/06/202415:30GlobeNewswire Inc.Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
04/06/202415:30Business WireFIS to Present at Upcoming ConferenceNYSE:FISFidelity National Information Services Inc

Su Consulta Reciente

USI
USTECH100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
TSLA
Tesla
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
NYSE
XOM
Exxon Mobil
AMEX
SPY
SPDR S&P 500
NYSE
MCD
McDonalds
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
NYSE
CVX
Chevron
NYSE
KO
Coca Cola
FX
USDMXN
US Dollar vs MXN
NASDAQ
NVDA
NVIDIA
COIN
SOLUSD
Solana
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados